|
|
Article: Inhaled insulin increases lung cancer risk.(IN THE NEWS)
- Article from:
- Life Extension
- Article date:
- September 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 LE Publications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A groundbreaking report by Dr. T.R. Shantha in the September 2007 issue of Life Extension warned that inhaled insulin could increase cancer risk. (1) Two months later, Pfizer Pharmaceuticals, the largest maker of inhaled insulin, abruptly halted sales of its product Exubera[R]. (2)
[ILLUSTRATION OMITTED]
A new study may reveal why. A review of clinical trial data shows a dramatic increase in lung cancer incidence among users of inhaled insulin. (3)
Insulin is a weak growth factor that may promote aberrant cell growth. (1) The amount of insulin used in inhaled products is three to ten times greater than the amount diabetics use for subcutaneous ...